XOMA Corp Contracts & Agreements
232 Contracts & Agreements
- Business Finance (101 contracts)
- Business Operations (21)
- Human Resources (52)
- Intellectual Property (18)
- Mergers & Acquisitions (1)
- Real Estate (8)
- Uncategorized (31)
- Description of Registrants Securities (Filed With SEC on March 8, 2024)
- Letter Amendment to Officer Employment Agreement dated November 1, 2022, between XOMA Corporation and Thomas Burns (Filed With SEC on March 8, 2024)
- Amended and Restated Officer Employment Agreement, dated January 8, 2024, between XOMA Corporation and Owen Hughes (Filed With SEC on March 8, 2024)
- Loan Agreement dated December 15, 2023, between XRL 1 LLC, the lenders from time to time party thereto and Blue Owl Capital Corporation (Filed With SEC on March 8, 2024)
- Sale, Contribution and Servicing Agreement (Filed With SEC on March 8, 2024)
- Office Lease dated June 27, 2023 between KBSIII Towers at Emeryville, LLC and XOMA (US) LLC (Filed With SEC on March 8, 2024)
- Agreement and Plan of Merger between the Company, Kinnate and Merger Sub, dated February 16, 2024 (Filed With SEC on February 16, 2024)
- Form of Warrant (December 2023) ($35.00 Exercise Price) (Filed With SEC on December 19, 2023)
- Form of Warrant (December 2023) ($42.50 Exercise Price) (Filed With SEC on December 19, 2023)
- Form of Warrant (December 2023) ($50.00 Exercise Price) (Filed With SEC on December 19, 2023)
- Assignment and Assumption Agreement, dated as of June 21, 2023, by and between XOMA (US) LLC and LadRx Corporation (Filed With SEC on August 8, 2023)
- Royalty Purchase Agreement, dated as of June 21, 2023, by and between XOMA (US) LLC and LadRx Corporation (Filed With SEC on August 8, 2023)
- Form of Performance Unit Agreement (Filed With SEC on May 18, 2023)
- Payment Interest Purchase Agreement, dated March 29, 2023, by and between Aptevo Therapeutics Inc. and XOMA (US) LLC (Filed With SEC on May 9, 2023)
- Description of Registrants Securities (Filed With SEC on March 9, 2023)
- The Amended Retention and Severance Plan dated, October 25, 2022 (Filed With SEC on March 9, 2023)
- Officer Employment Agreement, dated January 3, 2023, between XOMA Corporation and Owen Hughes (Filed With SEC on March 9, 2023)
- Officer Employment Agreement, dated January 3, 2023, between XOMA Corporation and Bradley Sitko (Filed With SEC on March 9, 2023)
- Intellectual Property Acquisition Agreement, dated November 21, 2022 between XOMA Corporation and ObsEva, SA (Filed With SEC on March 9, 2023)
- License Agreement, dated July 26, 2021, between ObsEva, SA and Organon International GmbH (Filed With SEC on March 9, 2023)
- License Agreement, dated June 10, 2015, between ObsEva, SA and Ares Trading S.A (Filed With SEC on March 9, 2023)
- IL-1b Target License Agreement, dated August 24, 2017, by and between XOMA Corporation and Novartis Pharma AG (Filed With SEC on November 3, 2022)
- License Agreement, dated August 24, 2017, by and between XOMA Corporation and Novartis Pharma AG (Filed With SEC on November 3, 2022)
- License Agreement, dated March 23, 2016, between XOMA Corporation and Ology Bioservices Inc. (formerly Nanotherapeutics Inc., now a wholly owned subsidiary of National Resilience,... (Filed With SEC on November 3, 2022)
- Amendment and Restatement, dated February 2, 2017, to the Asset Purchase Agreement, dated November 4, 2015, and License Agreement, dated March 23, 2016, between XOMA Corporation... (Filed With SEC on November 3, 2022)
- The Retention and Severance Plan dated, March 31, 2022 (Filed With SEC on May 5, 2022)
- Letter Amendment to Officer Employment Agreement dated August 7, 2017, between XOMA Corporation and Thomas Burns (Filed With SEC on May 5, 2022)
- Description of Registrants Securities (Filed With SEC on March 8, 2022)
- Amended and Restated Employment Agreement, dated December 15, 2021, between XOMA Corporation and James R. Neal (Filed With SEC on March 8, 2022)
- Commercial Payment Purchase Agreement, dated October 6, 2021, by and among XOMA (US) LLC and Affitech Research AS (Filed With SEC on March 8, 2022)
- Royalty Purchase Agreement, dated July 14, 2021, by and among XOMA (US) LLC and Kuros Royalty Fund (US) LLC (Filed With SEC on November 4, 2021)
- Settlement and Release Agreement, dated April 15, 2021, by and among XOMA (US) LLC and Affimed N.V., Affimed GmbH Affimed (Filed With SEC on August 5, 2021)
- At Market Issuance Sales Agreement, dated August 5, 2021, by and between XOMA Corporation and B. Riley Securities, Inc (Filed With SEC on August 5, 2021)
- Royalty Purchase Agreement dated March 22, 2021 between XOMA (US) LLC and Viracta Therapeutics, Inc (Filed With SEC on May 6, 2021)
- Underwriting Agreement, dated as of April 6, 2021, by and among the Company and B. Riley Securities, Inc., as representative of the several underwriters named therein (Filed With SEC on April 8, 2021)
- Deposit Agreement, dated effective as of April 9, 2021, by and among the Company, American Stock Transfer & Trust Company LLC, as depositary, and the holders of the depositary... (Filed With SEC on April 8, 2021)
- Description of Registrants Securities (Filed With SEC on March 10, 2021)
- Form of Amended and Restated Indemnification Agreement for Directors and Officers (Filed With SEC on March 10, 2021)
- Non-Exclusive License Agreement, dated November 30, 2001, between XOMA Ireland Limited ("XOMA") Sesen Bio, Inc. and (formerly Viventia Biotech Inc.) (Filed With SEC on March 10, 2021)
- Amendment No. 1, dated July 24, 2020, to the Non-Exclusive License Agreement, dated November 30, 2001, between XOMA Ireland Limited ("XOMA") and Sesen Bio, Inc (Filed With SEC on March 10, 2021)
- Amendment No. 1, dated March 10, 2021, to the Common Stock Sales Agreement, dated December 18, 2018, by and between XOMA Corporation and H.C. Wainwright & Co., LLC (Filed With SEC on March 10, 2021)
- Underwriting Agreement, dated as of December 10, 2020, by and between the Company and B. Riley Securities, Inc., as representative of the several underwriters named therein (Filed With SEC on December 11, 2020)
- License Agreement between the Company and Novartis International Pharmaceutical Ltd., dated September 30, 2015 (this exhibit was previously filed under confidential treatment... (Filed With SEC on November 5, 2020)
- Amendment to Amended and Restated Research, Development and Commercialization Agreement, between the Company and Novartis Vaccine and Diagnostics, Inc., dated September 30, 2015... (Filed With SEC on November 5, 2020)
- Collaboration and License Agreement, dated as of March 5, 2020, by and between XOMA (US) LLC and Cadila Healthcare Limited (Filed With SEC on May 5, 2020)
- Amendment No. 3, dated March 31, 2020, to the Common Stock Purchase Agreement, dated December 6, 2017, between XOMA Corporation and Rezolute, Inc. (formerly AntriaBio, Inc.) (Filed With SEC on May 5, 2020)
- Description of Registrants Securities (Filed With SEC on March 10, 2020)
- Lease Termination Agreement, dated December 17, 2019, by and between XOMA Corporation and 7th Street Property General Partnership (Filed With SEC on March 10, 2020)
- Lease Termination Agreement, dated December 17, 2019, by and between XOMA Corporation and 7th Street Properties II (Filed With SEC on March 10, 2020)
- Investment Agreement, dated November 19, 2019 (Filed With SEC on November 20, 2019)
- Royalty Purchase Agreement dated September 26, 2019 between XOMA (US) LLC and Palobiofarma, S.L (Filed With SEC on November 5, 2019)
- Separation Agreement dated August 31, 2019 between the Company and Dee Datta (Filed With SEC on November 5, 2019)
- Royalty Purchase Agreement dated April 7, 2019, between XOMA (US) LLC and Aronora, Inc (Filed With SEC on August 6, 2019)
- Form of Warrant (March 2019 Warrant) (Filed With SEC on May 6, 2019)
- First Amendment, dated March 4, 2019, to the Loan and Security Agreement dated May 7, 2018, between XOMA Corporation, XOMA (US) LLC and XOMA Technology, Ltd. and Silicon Valley... (Filed With SEC on May 6, 2019)
- Amendment No. 2, dated January 7, 2019, to the License Agreement, dated December 6, 2017, between XOMA (US) LLC and Rezolute, Inc. (formerly AntriaBio) (Filed With SEC on March 7, 2019)
- Amendment No. 2, dated January 7, 2019, to the Common Stock Purchase Agreement, dated December 6, 2017, between XOMA (US) LLC and Rezolute, Inc. (formerly AntriaBio) (Filed With SEC on March 7, 2019)
- Common Stock Sales Agreement, dated December 18, 2018, by and between XOMA Corporation and H.C. Wainwright & Co., LLC (Filed With SEC on December 18, 2018)
- Royalty Purchase Agreement dated September 20, 2018, between XOMA Corporation and Agenus Inc (Filed With SEC on November 7, 2018)
- Investment Agreement, dated November 6, 2018 (Filed With SEC on November 7, 2018)
- Form of Warrant (May 2018 Warrant) (Filed With SEC on August 7, 2018)
- Loan and Security Agreement dated May 7, 2018, between XOMA Corporation, XOMA (US) LLC and XOMA Technology, Ltd. and Silicon Valley Bank (Filed With SEC on August 7, 2018)
- Officer Employment Agreement, dated April 27, 2018, between XOMA Corporation and Deepshikha Datta (Filed With SEC on August 7, 2018)
- Change of Control Severance Agreement, dated April 27, 2018, between XOMA Corporation and Deepshikha Datta (Filed With SEC on August 7, 2018)
- Amendment No. 1, dated July 19, 2018, to the Officer Employment Agreement, dated April 27, 2018, between XOMA Corporation and Deepshikha Datta (Filed With SEC on August 7, 2018)
- Amendment No. 1, dated March 30, 2018, to the License Agreement, dated December 6, 2017, between XOMA (US) LLC and Rezolute, Inc. (formerly AntriaBio, Inc.) (Filed With SEC on May 9, 2018)
- Amendment No.1, dated March 30, 2018 to the Common Stock Purchase Agreement, dated December 6, 2017, between XOMA Corporation and Rezolute, Inc. (formerly AntriaBio, Inc.) (Filed With SEC on May 9, 2018)
- Amendment to Secured Note Agreement, executed September 22, 2017, by and between Novartis Vaccines and Diagnostics, Inc. (formerly Chiron Corporation) and XOMA (US) LLC (Filed With SEC on March 7, 2018)
- Amendment No. 1, dated December 20, 2016, to Loan and Security Agreement, dated February 27, 2015, by and among XOMA Corporation, XOMA(US) LLC and XOMA Commercial as borrowers and... (Filed With SEC on March 7, 2018)
- Amendment No. 3, effective January 17, 2017, to the Loan Agreement, effective December 30, 2010, by and among XOMA (US) LLC, Les Laboratoires Servier and Institut de Recherches... (Filed With SEC on March 7, 2018)
- License Agreement, dated December 6, 2017, between XOMA (US) LLC and Rezolute, Inc. (formerly AntriaBio) (Filed With SEC on March 7, 2018)
- Common Stock Purchase Agreement, dated December 6, 2017, between XOMA (US) LLC and Rezolute, Inc. (formerly AntriaBio) (Filed With SEC on March 7, 2018)
- Common Stock Purchase Agreement, dated August 24, 2017, by and between XOMA Corporation and Novartis Pharma AG (Filed With SEC on November 6, 2017)
- IL-1b Target License Agreement, dated August 24, 2017, by and between XOMA Corporation and Novartis Pharma AG (Filed With SEC on November 6, 2017)
- License Agreement, dated August 24, 2017, by and between XOMA Corporation and Novartis Pharma AG (Filed With SEC on November 6, 2017)
- XOMA CORPORATION AMENDED AND RESTATED 2010 LONG TERM INCENTIVE AND STOCK AWARD PLAN (as amended through May 18, 2017) (Filed With SEC on May 24, 2017)
- XOMA CORPORATION AMENDED 2015 EMPLOYEE STOCK PURCHASE PLAN (as amended through May 18, 2017) (Filed With SEC on May 24, 2017)
- PROTECTIVE RIGHTS AGREEMENT (Filed With SEC on March 16, 2017)
- EXECUTION VERSION PROTECTIVE RIGHTS AGREEMENT (Filed With SEC on March 16, 2017)
- Incorporated Under the Laws of the State of Delaware on December 31, 2011 (Filed With SEC on February 16, 2017)
- XOMA CORPORATION AMENDED AND RESTATED 2010 LONG TERM INCENTIVE AND STOCK AWARDPLAN (Filed With SEC on May 23, 2016)
- XOMA CORPORATION 2016 INCENTIVE COMPENSATION PLAN SECTION 1 BACKGROUND AND PURPOSE (Filed With SEC on May 23, 2016)
- XOMA CORPORATION Warrant to Purchase Shares of Common Stock (Filed With SEC on May 4, 2016)
- xoma corporation 2016 INCENTIVE COMPENSATION PLAN SECTION 1 BACKGROUND AND PURPOSE (Filed With SEC on May 4, 2016)
- XOMA CORPORATION CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on March 9, 2016)
- CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on March 9, 2016)
- OFFICER EMPLOYMENT AGREEMENT (Filed With SEC on March 9, 2016)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on March 9, 2016)
- SETTLEMENT AND AMENDED LICENSE AGREEMENT (Filed With SEC on March 9, 2016)
- ASSET PURCHASE AGREEMENT by and among AGENUS WEST, LLC and AGENUS INC. (solely with respect to its obligations under Sections4.4, Section 8.3, and Article7) and XOMA CORPORATION... (Filed With SEC on March 9, 2016)
- XOMA CORPORATION $75,000,000 SALESAGREEMENT (Filed With SEC on November 12, 2015)
- LICENSE AGREEMENT by and between XOMA (US) LLC and NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. Table of Contents (continued) (Filed With SEC on November 6, 2015)
- NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. 250 Massachusetts Ave. Cambridge, MA 02139 September 30, 2015 (Filed With SEC on November 6, 2015)
- NOVARTIS VACCINES AND DIAGNOSTICS, INC. 5300 Chiron Way Emeryville, California 94608 September 30, 2015 (Filed With SEC on November 6, 2015)
- Letter Agreement, dated June 19, 2015, by and between XOMA (US) LLC and Novartis Vaccines and Diagnostics, Inc (Filed With SEC on August 10, 2015)
- Form of Warrant (February 2015 Warrants) (Filed With SEC on May 7, 2015)
- Loan and Security Agreement, dated February 27, 2015, by and among XOMA Corporation, XOMA(US) LLC and XOMA Commercial as borrowers and Hercules Technology Growth Capital, Inc., as... (Filed With SEC on May 7, 2015)
- Employment Agreement by and between XOMA Corporation and Thomas Burns, dated as of April 3, 2015 (Filed With SEC on May 7, 2015)
- Change of Control Severance Agreement by and between XOMA Corporation and Thomas Burns, dated as of April 3, 2015 (Filed With SEC on May 7, 2015)
- Amendment No. 2, effective January 9, 2015, to the Loan Agreement, effective December 30, 2010, by and among XOMA (US) LLC, Les Laboratoires Servier and Institut de Recherches... (Filed With SEC on March 11, 2015)
- Amendment No. 2, effective January 9, 2015, to the Amended and Restated Collaboration and License Agreement, effective February 14, 2012, by and among XOMA (US) LLC, Les... (Filed With SEC on March 11, 2015)
- Amendment No. 1, effective November 4, 2014, to the Amended and Restated Collaboration and License Agreement, effective February 14, 2012, by and among XOMA (US) LLC (assigned... (Filed With SEC on March 11, 2015)
- Amendment No. 1 (Consent, Transfer, Assumption and Amendment), effective August 12, 2013, to the Loan Agreement, effective December 30, 2010, by and among XOMA (US) LLC, Les... (Filed With SEC on March 11, 2015)
- 8,097,165 Shares andWarrants to Purchase 8,097,165 Shares XOMA Corporation Common Stock PLACEMENT AGENT AGREEMENT (Filed With SEC on December 9, 2014)
- XOMA CORPORATION WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on December 9, 2014)
- SUBSCRIPTION AGREEMENT (Filed With SEC on December 9, 2014)
- Second Amendment to Loan Agreement, by and between General Electric Capital Corporation, the Company as guarantor, XOMA (US) LLC as borrower, and certain other wholly-owned... (Filed With SEC on November 6, 2014)
- Third Amendment to Loan Agreement, by and between General Electric Capital Corporation, the Company as guarantor, XOMA (US) LLC as borrower, and certain other wholly-owned... (Filed With SEC on November 6, 2014)
- First Amendment, dated October 28, 2014, to the License Agreement between XOMA (US) LLC (assigned to it by XOMA Ireland Limited) and BP Biofuels Advanced Technology Inc.... (Filed With SEC on November 6, 2014)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 12, 2014)
- Officer Employment Agreement dated March 19, 2013 between XOMA Corporation and Paul Rubin (Filed With SEC on March 12, 2014)
- Officer Employment Agreement dated March 10, 2014 between XOMA Corporation and Pat Scannon (Filed With SEC on March 12, 2014)
- Retention Benefit Agreement entered into between XOMA Corporation and John Varian, dated March 11, 2014 (Filed With SEC on March 12, 2014)
- Lease of premises at 804 Heinz Street, Berkeley, California dated February 13, 2013 (Filed With SEC on March 12, 2014)
- Lease of premises at 2910 Seventh Street, Berkeley, California dated February 13, 2013 (Filed With SEC on March 12, 2014)
- First amendment to lease of premises at 2910 Seventh Street, Berkeley, California dated February 22, 2013 (Filed With SEC on March 12, 2014)
- Lease of premises at 5860 and 5864 Hollis Street, Emeryville, California dated February 13, 2013 (Filed With SEC on March 12, 2014)
- Underwriting Agreement, dated December 13, 2013 (Filed With SEC on December 13, 2013)
- Consent, Transfer, Assumption and Amendment Agreement, dated August 12, 2013, by and among XOMA Ireland Limited, XOMA (US) LLC and Les Laboratoires Servier (Filed With SEC on November 7, 2013)
- Promissory Note, dated August 12, 2013, from XOMA (US) LLC to Les Laboratoires Servier (Filed With SEC on November 7, 2013)
- Second Amendment to Loan Agreement, dated August 12, 2013, by and among XOMA (US) LLC, XOMA Corporation and General Electric Capital Corporation (Filed With SEC on November 7, 2013)
- Underwriting Agreement, dated August 19, 2013 (Filed With SEC on August 21, 2013)
- Officer Employment Agreement by and between XOMA Corporation and Thomas Klein dated March 18, 2013 (Filed With SEC on May 8, 2013)
- Underwriting Agreement, dated October 24, 2012 (Filed With SEC on October 24, 2012)
- Warrant issued to General Electric Capital Corporation, dated September 27, 2012 (Filed With SEC on October 3, 2012)
- First Amendment to Loan Agreement, by and between General Electric Capital Corporation, the Company as guarantor, XOMA (US) LLC as borrower, and certain other wholly-owned... (Filed With SEC on October 3, 2012)
- Form of Warrant (December 2011 Warrants) (Filed With SEC on March 14, 2012)
- Form of Stock Option Agreement for Amended and Restated 2010 Long Term Incentive and Stock Award Plan (Filed With SEC on March 14, 2012)
- Form of Restricted Stock Unit Agreement for Amended and Restated 2010 Long Term Incentive and Stock Award Plan (Filed With SEC on March 14, 2012)
- Amendment No. 1 to CEO Incentive Compensation Plan (Filed With SEC on March 14, 2012)
- Employment Agreement effective as of January 4, 2012 between XOMA (US) LLC and John Varian (Filed With SEC on March 14, 2012)
- Change of Control Agreement entered into between XOMA Ltd. and John Varian, dated January 4, 2012 (Filed With SEC on March 14, 2012)
- Amendment No. 1 to Amended and Restated Research, Development and Commercialization Agreement, effective as of April 30, 2010, by and between Novartis Vaccines and Diagnostics,... (Filed With SEC on March 14, 2012)
- Amended and Restated Collaboration and License Agreement dated as of February 14, 2012, by and between XOMA Ireland Limited, Les Laboratoires Servier and Institut de Recherches... (Filed With SEC on March 14, 2012)
- Loan Agreement dated as of December 30, 2011, among XOMA (US) LLC, as Borrower, XOMA Ltd., as Parent, each other loan party from time to time party thereto, General Electric... (Filed With SEC on March 14, 2012)
- Guaranty, Pledge and Security Agreement dated as of December 30, 2011, among XOMA (US) LLC, each other guarantor from time to time party thereto and General Electric Capital... (Filed With SEC on March 14, 2012)
- Amended and Restated License and Commercialization Agreement effective as of January 11, 2012, by and between Les Laboratoires Servier and XOMA Ireland Limited (with certain... (Filed With SEC on March 14, 2012)
- Amended and Restated Trademark License Agreement entered into as of January 11, 2012, between Biofarma and XOMA Ireland Limited (with certain confidential information omitted,... (Filed With SEC on March 14, 2012)
- Master Services Agreement dated as of November 9, 2009, between Medpace, Inc. and XOMA (US) LLC (with certain confidential information omitted, which omitted information is the... (Filed With SEC on March 14, 2012)
- Amendment No. 1 to Master Services Agreement dated as of October 4, 2011, between Medpace, Inc. and XOMA (US) LLC (with certain confidential information omitted, which omitted... (Filed With SEC on March 14, 2012)
- [Underwriting Agreement] 29,669,154 Shares Warrants to purchase 14,834,577 Shares XOMA Corporation Common Stock ($0.0075 Par Value) EQUITY UNDERWRITING AGREEMENT (Filed With SEC on March 7, 2012)
- [Form of Warrant] XOMA CORPORATION Warrant To Purchase Common Stock (Filed With SEC on March 7, 2012)
- [Amendment No. 3 to Shareholder Rights Agreement] (Filed With SEC on March 7, 2012)
- Form of Restricted Share Unit Agreement for 2010 Long Term Incentive and Share Award Plan (Filed With SEC on November 9, 2011)
- AWARD/CONTRACT (Filed With SEC on October 4, 2011)
- CONSULTING AGREEMENT (Filed With SEC on September 1, 2011)
- XOMA (US) LLC EMPLOYMENT AGREEMENT NAME:John Varian TITLE:Interim Chief Executive Officer (Filed With SEC on September 1, 2011)
- Foreign Exchange and Options Master Agreement (FEOMA) dated as of May 16, 2011 between Royal Bank of Canada and XOMA Ltd., with letter agreement dated May 17, 2011 (Filed With SEC on August 4, 2011)
- EMPLOYMENT AGREEMENT (Filed With SEC on June 16, 2011)
- Amendment to Shareholder Rights Agreement dated December 21, 2010 between XOMA Ltd. and Wells Fargo Bank, N.A. as Rights Agent (Filed With SEC on March 10, 2011)
- Form of Change of Control Severance Agreement entered into between XOMA Ltd. and certain of its executives, with reference schedule (Filed With SEC on March 10, 2011)
- GSSM License Agreement, effective as of May 2, 2008, by and between Verenium Corporation and XOMA Ireland Limited (with certain confidential information omitted, which omitted... (Filed With SEC on March 10, 2011)
- Collaboration and License Agreement dated as of December 30, 2010, by and between XOMA Ireland Limited, Les Laboratoires Servier and Institut de Recherches Servier (with certain... (Filed With SEC on March 10, 2011)
- Loan Agreement dated as of December 30, 2010, by and between XOMA Ireland Limited and Les Laboratoires Servier (with certain confidential information omitted, which omitted... (Filed With SEC on March 10, 2011)
- Second Amendment to Agreement dated September 15, 2008, between XOMA (US) LLC and National Institute of Allergy and Infectious Diseases (Filed With SEC on November 4, 2010)
- Royalty Purchase Agreement, dated as of August 12, 2010, by and among XOMA CDRA LLC, XOMA (US) LLC, XOMA Ltd., the buyer named therein (with certain confidential information... (Filed With SEC on November 4, 2010)
- At Market Issuance Sales Agreement (Filed With SEC on October 26, 2010)
- COMMON SHARE PURCHASE AGREEMENT Dated July 23, 2010 by and between XOMA LTD. and AZIMUTH OPPORTUNITY LTD. TABLE OF CONTENTS (Filed With SEC on July 23, 2010)
- FORM OF AMENDED AND RESTATED (Filed With SEC on March 11, 2010)
- FORM OF XOMA LTD. (Filed With SEC on March 11, 2010)
- DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on March 11, 2010)
- 42,000,000 Units XOMA LTD. UNDERWRITING AGREEMENT (Filed With SEC on February 2, 2010)
- XOMA LTD. WARRANTTO PURCHASE COMMON SHARES (Filed With SEC on February 2, 2010)
- WARRANT AMENDMENT AGREEMENT (Filed With SEC on February 2, 2010)
- WARRANT AMENDMENT AGREEMENT (Filed With SEC on February 2, 2010)
- XOMA LTD. AMENDEDAND RESTATED WARRANT TO PURCHASECOMMON STOCK (Filed With SEC on February 2, 2010)
- [FORM OF WARRANT] XOMA LTD. AMENDED AND RESTATED (Filed With SEC on February 2, 2010)
- [*] indicates that a confidentialportion of the text of this agreement has been omitted. AGREEMENT RELATED TO (Filed With SEC on November 9, 2009)
- [*] indicates that a confidentialportion of the text of this agreement has been omitted. DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on November 9, 2009)
- At Market Issuance Sales Agreement (Filed With SEC on November 9, 2009)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on June 10, 2009)
- [FORMOF WARRANT] XOMALtd. WarrantTo Purchase Common Stock (Filed With SEC on June 10, 2009)
- ADDENDUMA INDEMNIFICATIONPROVISIONS (Filed With SEC on June 10, 2009)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on May 19, 2009)
- XOMALtd. WarrantTo Purchase Common Stock (Filed With SEC on May 19, 2009)
- XOMA LTD. 1992 DIRECTORS SHARE OPTION PLAN (Filed With SEC on March 11, 2009)
- FORM OF AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 11, 2009)
- FORM OF XOMA LTD. AMENDED AND RESTATED CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on March 11, 2009)
- AMENDED AND RESTATED RESEARCH, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on March 11, 2009)
- MANUFACTURING AND TECHNOLOGY TRANSFER AGREEMENT (Filed With SEC on March 11, 2009)
- SECOND AMENDMENT TO COLLABORATION AGREEMENT (Filed With SEC on March 11, 2009)
- CONTRACT TABLE OF CONTENTS (Filed With SEC on November 10, 2008)
- COMMON SHARE PURCHASE AGREEMENT DatedOctober 21, 2008 byand between XOMALTD. and AZIMUTHOPPORTUNITY LTD. TABLE OFCONTENTS (Filed With SEC on October 22, 2008)
- Share Option Agreement Under the XOMA Ltd. (Filed With SEC on March 11, 2008)
- Non-Qualified Share Option Agreement Under the XOMA Ltd. (Filed With SEC on March 11, 2008)
- Amendment No. 3 to the XOMA LTD. RESTRICTED SHARE PLAN (Filed With SEC on March 11, 2008)
- XOMA LTD. 1992 DIRECTORS SHARE OPTION PLAN (Filed With SEC on March 11, 2008)
- Share Option Agreement Under the XOMA Ltd. (Filed With SEC on March 11, 2008)
- Share Option Agreement Under the XOMA Ltd. (Filed With SEC on March 11, 2008)
- XOMA Ltd. CEO Incentive Compensation Plan (Filed With SEC on March 11, 2008)
- XOMA Ltd. Bonus Compensation Plan (Filed With SEC on March 11, 2008)
- FORM OF EMPLOYMENT AGREEMENT (Filed With SEC on August 16, 2007)
- XOMA LTD. CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on August 16, 2007)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2007)
- XOMA LTD. CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on August 7, 2007)
- Share Option Agreement Under the XOMA Ltd. 1981 Share Option Plan (Filed With SEC on August 7, 2007)
- Share Option Agreement Under the XOMA Ltd. 1981 Share Option Plan (Filed With SEC on August 7, 2007)
- Share Option Agreement Under the XOMA Ltd. 1981 Share Option Plan (Filed With SEC on August 7, 2007)
- Non-Qualified Share Option Agreement Under the XOMA Ltd. Restricted Share Plan (Filed With SEC on August 7, 2007)
- XOMA Ltd. Non-Qualified Share Option Agreement (Filed With SEC on August 7, 2007)
- CONSULTING AGREEMENT (Filed With SEC on August 7, 2007)
- FIRST AMENDMENT TOCOLLABORATION AGREEMENT (Filed With SEC on May 10, 2007)
- AMENDED AND RESTATED INDEMNIFICATION AGREEMENT (Filed With SEC on March 8, 2007)
- AMENDED AND RESTATED INDEMNIFICATION AGREEMENT (Filed With SEC on March 8, 2007)
- AMENDED AND RESTATED INDEMNIFICATION AGREEMENT (Filed With SEC on March 8, 2007)
- [*] indicates that a confidential portion of the text of this agreement has been omitted. AMENDED ANDRESTATED LICENSE AGREEMENT (Filed With SEC on March 8, 2007)
- [*] indicates that a confidential portion of the text of this agreement has been omitted. COLLABORATIONAGREEMENT (Filed With SEC on March 8, 2007)
- U.S. $35,000,000 LOAN AGREEMENT Dated as of November 9, 2006 between (Filed With SEC on March 8, 2007)
- FIFTH AMENDMENT TO OFFICE LEASE (Filed With SEC on August 9, 2006)
- COLLABORATION AGREEMENT (Filed With SEC on August 9, 2006)
- DETAILED TABLE OF CONTRACT CONTENTS (Filed With SEC on August 9, 2006)
- FORM OF EMPLOYMENT AGREEMENT (Filed With SEC on July 12, 2006)
- FORM OF XOMA LTD. CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on July 12, 2006)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 8, 2005)
- RESEARCH, DEVELOPMENT ANDCOMMERCIALIZATION AGREEMENT dated as of May 26, 2005 (Filed With SEC on August 8, 2005)
- SECURED NOTE AGREEMENT (Filed With SEC on August 8, 2005)
- LICENSE AGREEMENT (Filed With SEC on August 8, 2005)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 9, 2005)
- AMENDMENT TO THE XOMA LTD.1981 SHARE OPTION PLAN (Filed With SEC on March 15, 2005)
- Amendment No. 2 to the XOMA LTD. 1981 SHARE OPTION PLAN (Filed With SEC on March 15, 2005)
- AMENDMENT TO THE XOMA LTD.RESTRICTED SHARE PLAN (Filed With SEC on March 15, 2005)
- Amendment No. 2 to the XOMA LTD. RESTRICTED SHARE PLAN (Filed With SEC on March 15, 2005)
- XOMA LTD. (Filed With SEC on March 15, 2005)
- AMENDMENT NO. 1 (Filed With SEC on March 15, 2005)
- AMENDMENT TO THE XOMA LTD. 1998 EMPLOYEE SHARE PURCHASE PLAN (Filed With SEC on March 15, 2005)
- AMENDMENT NO. 2 TO THE XOMA LTD. 1998 EMPLOYEE SHARE PURCHASE PLAN (Filed With SEC on March 15, 2005)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 15, 2005)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 15, 2005)
- SECOND AMENDED AND RESTATED COLLABORATION AGREEMENT (Filed With SEC on March 15, 2005)
- 10 U.S.C.2304(c)( ) 41 U.S.C. 253(c)( ) (Filed With SEC on March 15, 2005)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 15, 2004)
- AGREEMENT (Filed With SEC on March 15, 2004)